文献速递胃肠动力与功能性疾病

抗抑郁药对功能性消化不良患者胃功能的影响

Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.
PubMed 文献 · Am J Gastroenterol · 2017-12-19

这项多中心前瞻性试验将292例功能性消化不良患者随机分配至阿米替林50mg、艾司西酞普兰10mg或安慰剂治疗12周。两种抗抑郁药均未改变胃排空,但胃容受性提高(P=0.02),总体症状评分较安慰剂改善(P=0.04),餐后腹胀在阿米替林(P=0.03)和艾司西酞普兰(P=0.02)组均改善。

要点

  • 阿米替林50mg改善功能性消化不良症状,但不延迟胃排空,即使基线胃排空延迟者亦然。
  • 低剂量抗抑郁药治疗提高胃容受性(P=0.02),但具体机制不明,需进一步研究。
  • 餐后腹胀在阿米替林(P=0.03)和艾司西酞普兰(P=0.02)组均改善。

核心结论

  • 阿米替林50mg改善功能性消化不良症状但不延迟胃排空,即使基线胃排空延迟者亦然。
  • 低剂量抗抑郁药治疗提高胃容受性,但确切作用机制不明,需进一步研究。

研究设计与样本

  • 多中心前瞻性试验,将功能性消化不良患者随机分配至阿米替林50mg、艾司西酞普兰10mg或匹配安慰剂治疗12周。
  • 共随机292例受试者,平均年龄44岁,21%有胃排空延迟。
  • 采用意向性治疗分析纳入所有随机受试者;胃容受性通过单光子发射计算机断层成像在部分患者中评估。

主要发现

  • 两种抗抑郁药均未改变胃排空,即使基线胃排空延迟者亦然。
  • 胃容受性随抗抑郁药治疗提高(P=0.02)。
  • 两种抗抑郁药均未影响营养饮料试验的最大耐受容量,但总体症状评分较安慰剂改善(P=0.04)。
  • 合并EPS-PDS亚型(48%)患者基线时营养饮料试验最大耐受容量低于EPS组(P=0.02)。
  • 餐后腹胀在阿米替林组(P=0.03)和艾司西酞普兰组(P=0.02)均改善。

局限性

  • 胃容受性仅在部分患者中评估。
  • 确切作用机制不明,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Functional dyspepsia (FD) is a highly prevalent functional bowel disorder. The effects of antidepressant therapy (ADTx) on gastric sensorimotor function in FD patients are poorly understood. AIMS: Determine whether FD and subtypes with abnormalities in gastric function respond differently to ADTx compared to those with normal physiology. METHODS: This multicenter, prospective trial randomized FD patients to 12 weeks of amitriptyline (AMI; 50 mg), escitalopram (ESC; 10 mg), or matching placebo. Demographics, symptoms, psychological distress, gastric emptying, and satiation were measured. Gastric accommodation (GA) using single-photon emission computed tomography imaging was performed in a subset of patients. An intent to treat analysis included all randomized subjects. The effect of treatment on gastric emptying was assessed using ANCOVA. A post hoc appraisal of the data was performed categorizing patients according to the Rome III subgrouping (PDS and EPS). RESULTS: In total, 292 subjects were randomized; mean age=44 yrs. 21% had delayed gastric emptying. Neither antidepressant altered gastric emptying, even in those with baseline delayed gastric emptying. GA increased with ADTx (P=0.02). Neither antidepressant affected the maximal-tolerated volume (MTV) of the nutrient drink test although aggregate symptom scores improved compared to placebo (P=0.04). Patients with the combined EPS-PDS subtype (48%) had a lower MTV on the nutrient drink test compared to the EPS group at baseline (P=0.02). Postprandial bloating improved with both AMI (P=0.03) and ESC (P=0.02). CONCLUSIONS: Amitriptyline (50 mg) improves FD symptoms but does not delay gastric emptying, even in patients with baseline delayed gastric emptying. GA improved with low-dose ADTx; the precise mechanism of action is unknown warranting further study.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lacy BE, Saito YA, Camilleri M, et al. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia. Am J Gastroenterol. 2017. PMID: 29257140. doi:10.1038/ajg.2017.458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。